Prevention of fungal infection in patients with malignancy following cytotoxic chemotherapy and in other immunocompromised patients
- Vaginal Candidiasis
- Mucosal and Systemic Candidiasis
- Cryptococcal Meningitis
- Oropharyngeal and Oesophageal Candidiasis
NAFDAC REG NO:
Oropharyngeal and Oesophageal Candidiasis: (Adult) Start 200mg followed by 100mg per day for 30 days.
Mucosal and Systemic Candidiasis: (Adult) Start 400mg followed by 200mg per day for 28 days.
Vaginal Candidiasis: (Adult) A single oral dose of 150mg.
Immunocompromised Patients: (Adult) 50 – 100mg daily.
Dosage in Children: 6mg/kg followed by 3mg/kg once daily for two weeks.